After US approval, Japan OKs Leqembi, its first Alzheimer’s drug, developed by Eisai and Biogen
Japan’s health ministry has approved Leqembi, a drug for Alzheimer’s decease that was jointly developed by Japanese and U.S. pharmaceutical companies ByMARI YAMAGUCHI Associated Press September 26, 2023,…
Read more After US approval, Japan OKs Leqembi, its first Alzheimer’s drug, developed by Eisai and Biogen